Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Vrm International Pty Ltd. has 1 pending office action within the Biotechnology & Pharmaceuticals technology area. The prosecution of this portfolio is currently confined to 1 distinct art unit, which suggests a specialized technical focus. With a distinct examiner assigned to the case, the company's immediate interactions with the patent office are centralized. This focus allows the applicant to develop an understanding of the specific examination style prevalent in the 1 distinct art unit, potentially leading to more efficient prosecution outcomes.
IBRAHIM, MEDINA AHMED is the busiest examiner for this portfolio, overseeing the pending office action. The concentration of the portfolio in 1 distinct art unit and under a single examiner simplifies the management of the pending matter. For a company in the Biotechnology & Pharmaceuticals sector, this focus allows for a targeted legal strategy to address the specific concerns raised by the assigned examiner. The resolution of this pending office action will be a significant milestone for the company's intellectual property strategy in the Biotechnology & Pharmaceuticals field.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| IBRAHIM, MEDINA AHMED | 1 | 87.4% | +12.2% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18105912 | METHOD OF ECOLOGICAL STEM CELL DEVELOPMENT THAT STIMULATES GENE SHUFFLING AND HYBRID VIGOUR | IBRAHIM, MEDINA AHMED | 33d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18105912 | METHOD OF ECOLOGICAL STEM CELL DEVELOPMENT THAT STIMULATES GENE SHUFFLING AND HYBRID VIGOUR | IBRAHIM, MEDINA AHMED | 33d |
| Art Unit | Apps |
|---|---|
| 1662 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18105912 | METHOD OF ECOLOGICAL STEM CELL DEVELOPMENT THAT STIMULATES GENE SHUFFLING AND HYBRID VIGOUR | IBRAHIM, MEDINA AHMED | 1662 | §103§112 | Non-Final OA | 33d | Pending | Feb 06, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial